Bob Acropolis

Bob Acropolis is an experienced leader in commercial operations and analytics, currently serving as Executive Director of Commercial Operations and Analytics for Rare Disease at ANI Pharmaceuticals, Inc. since September 2021. In this role, Bob has overseen various aspects of commercial operations, including Sales Operations, Field Reporting, and Analytics, while playing a crucial part in the operational framework for the Cortrophin Gel product launch. Prior to ANI, Bob held several key positions at Sunovion Pharmaceuticals, leading Sales Operations and Veeva CRM, as well as managing substantial budgets and staff. Bob's career began with extensive experience at J. Knipper & Company, where contributions to revenue growth and operational strategy were significant. Bob holds a BS in Business Management from Quinnipiac University.